"Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis and Cyclin D1" is a 2011 study published in Cancer Prevention Research that investigates the combined effects of these drugs on tumor suppression. The research highlights how this combination leads to the degradation of cyclin D1 to prevent lung cancer development. Access the full article at AACR Journals .